Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle

被引:78
作者
Glatz, JFC
Schaap, FG
Binas, B
Bonen, A
van der Vusse, GJ
Luiken, JJFP
机构
[1] Maastricht Univ, CARIM, Dept Physiol, NL-6200 MD Maastricht, Netherlands
[2] Max Delbruck Ctr Mol Med, Dept Hypertens Res, Berlin, Germany
[3] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 2003年 / 178卷 / 04期
关键词
fatty acid-binding protein; fatty acid uptake; fatty acid oxidation; FABP null mice; skeletal muscle;
D O I
10.1046/j.1365-201X.2003.01166.x
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
The intracellular transport of long-chain fatty acids in muscle cells is facilitated to a great extent by heart-type cytoplasmic fatty acid-binding protein (H-FABP). By virtue of the marked affinity of this 14.5-kDa protein for fatty acids H-FABP dramatically increases their concentration in the aqueous cytoplasm by non-covalent binding, thereby facilitating both the transition of fatty acids from membranes to the aqueous space and their diffusional transport from membranes (e.g. sarcolemma) to other cellular compartments (e.g. mitochondria). Striking features are the relative abundance of H-FABP in muscle, especially in oxidative muscle fibres, and the modulation of the muscular H-FABP content in concert with the modulation of other proteins and enzymes involved in fatty acid handling and utilization. Newer studies with mice carrying a homozygous or heterozygous deletion of the H-FABP gene show that, in comparison with wild-type mice, hindlimb muscles from heterozygous animals have a markedly lowered (-66%) H-FABP content but unaltered palmitate uptake rate, while in hindlimb muscles from homozygous animals (no H-FABP present) palmitate uptake was reduced by 45%. These findings indicate that H-FABP is present in relative excess and plays a substantial, but merely permissive role in fatty acid uptake by skeletal muscles.
引用
收藏
页码:367 / 371
页数:5
相关论文
共 24 条
[1]
Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle [J].
Anderwald, C ;
Bernroider, E ;
Krssák, M ;
Stingl, H ;
Brehm, A ;
Bischof, MG ;
Nowotny, P ;
Roden, M ;
Waldhäusl, W .
DIABETES, 2002, 51 (10) :3025-3032
[2]
Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization [J].
Binas, B ;
Danneberg, H ;
McWhir, J ;
Mullins, L ;
Clark, AJ .
FASEB JOURNAL, 1999, 13 (08) :805-812
[3]
Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes [J].
Bonen, A ;
Benton, CR ;
Campbell, SE ;
Chabowski, A ;
Clarke, DC ;
Hang, XX ;
Glatz, JFC ;
Luiken, JJFP .
ACTA PHYSIOLOGICA SCANDINAVICA, 2003, 178 (04) :347-356
[4]
Faergeman NJ, 1997, BIOCHEM J, V323, P1
[5]
Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle [J].
Gilde, AJ ;
Van Bilsen, M .
ACTA PHYSIOLOGICA SCANDINAVICA, 2003, 178 (04) :425-434
[6]
Exercise and insulin increase muscle fatty acid uptake by recruiting putative fatty acid transporters to the sarcolemma [J].
Glatz, JFC ;
Bonen, A ;
Luiken, JJFP .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (04) :365-370
[7]
Cellular fatty acid-binding proteins: Their function and physiological significance [J].
Glatz, JFC ;
vanderVusse, GJ .
PROGRESS IN LIPID RESEARCH, 1996, 35 (03) :243-282
[8]
Unravelling the significance of cellular fatty acid-binding proteins [J].
Glatz, JFC ;
Storch, J .
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (03) :267-274
[9]
Glatz JFC, 1998, ADV EXP MED BIOL, V441, P207
[10]
Skeletal muscle lipid content and insulin resistance: Evidence for a paradox in endurance-trained athletes [J].
Goodpaster, BH ;
He, J ;
Watkins, S ;
Kelley, DE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) :5755-5761